Skip to main content

Court News

Latest court orders, judgments, and legal developments from Indian courts — AI-curated and summarized.

Section 124 in Non-Use Cancellation Proceedings
Calcutta High Court, Delhi High Courtintellectual_propertyprocedural

Section 124 in Non-Use Cancellation Proceedings

Courts diverge on whether Section 124 allows stay of infringement suits during non-use cancellation under Section 47. Calcutta and Delhi High Courts differ, raising uncertainty over procedural overlap in trademark law.

Oct 12, 2026Read more →
Weekly IP Roundup: Section 124 Stay in Trademark Cancellation Proceedings
Various High Courtsintellectual_propertyarbitration

Weekly IP Roundup: Section 124 Stay in Trademark Cancellation Proceedings

Analysts examine conflicting approaches of the Calcutta and Delhi High Courts on whether non-use cancellation proceedings under Section 47 of the Trade Marks Act can trigger an automatic stay under Section 124. The divergence highlights uncertainty in procedural interplay between infringement and rectification actions.

Oct 9, 2026Read more →
IPO Draft Pharma Guidelines Criticized for Legal Errors
Indian Patent Office (Administrative Guidelines)intellectual_propertypharmaceutical

IPO Draft Pharma Guidelines Criticized for Legal Errors

IPO's 2026 Draft Guidelines for Pharma Patents contain misquotations and misinterpretations, say experts. Flawed approach risks disrupting patent examination standards.

Oct 6, 2026Read more →
IPO’s 2026 Draft Pharma Guidelines Criticised
Not Applicableintellectual_propertypharmaceutical

IPO’s 2026 Draft Pharma Guidelines Criticised

The IPO’s Draft Guidelines for Examination of Pharmaceutical Patent Applications, 2026 face severe criticism for misquoting provisions and misinterpreting patentability standards, raising concerns over examination consistency and legal accuracy.

Oct 4, 2026Read more →
IPO's 2026 Pharma Patent Guidelines Criticised
Not Applicableintellectual_propertypharmaceutical

IPO's 2026 Pharma Patent Guidelines Criticised

The IPO's Draft Guidelines for Examination of Pharmaceutical Patent Applications (2026) face criticism for misquoting statutes and introducing inconsistent standards, prompting calls for comprehensive revision before finalisation.

Oct 3, 2026Read more →
Criticism of IPO’s 2026 Draft Pharmaceutical Patent Guidelines
N/Aintellectual_propertypharmaceutical

Criticism of IPO’s 2026 Draft Pharmaceutical Patent Guidelines

The IPO’s 2026 Draft Guidelines face strong critique for misquoting law and risking disruption to patent prosecution in pharmaceuticals; calls grow for immediate revision.

Sep 30, 2026Read more →
Critical Analysis of Jyothy Labs v. Dabur Trademark Case
Bombay High Courtintellectual_property

Critical Analysis of Jyothy Labs v. Dabur Trademark Case

The Bombay High Court's ruling in Jyothy Labs v. Dabur highlights significant issues in trademark protection, questioning the underlying legal reasoning.

Sep 10, 2026Read more →
The Licensing Challenge: IPRS v Hotel Appolo
Calcutta High Courtintellectual_property

The Licensing Challenge: IPRS v Hotel Appolo

The IPRS v Hotel Appolo case illustrates the licensing complexities faced by hotels concerning copyright compliance for in-room television usage.

Sep 9, 2026Read more →
Analysis of Copyright Office's Decision on AI Artwork
Copyright Officeintellectual_property

Analysis of Copyright Office's Decision on AI Artwork

The Copyright Office's refusal to register Thaler's AI-generated artwork highlights ongoing debates in originality and authorship in the digital age.

Sep 9, 2026Read more →
Critique of Bombay HC's Ruling in Jyothy Labs v. Dabur
Bombay High Courtintellectual_property

Critique of Bombay HC's Ruling in Jyothy Labs v. Dabur

A critical analysis reveals potential doctrinal issues in the Bombay HC's decision on the NEEM trademark case, questioning the court's legal reasoning.

Sep 9, 2026Read more →
New Draft Guidelines for Pharma and Biotech Patent Applications Released
Controller General of Patents, Designs and Trademarksintellectual_propertycorporate

New Draft Guidelines for Pharma and Biotech Patent Applications Released

The CGPDTM has invited comments on new draft guidelines aimed at streamlining patent application procedures for pharmaceutical and biotechnology inventions.

Sep 9, 2026Read more →
IPRS v. Hotel Appolo: Licensing and Copyright Issues
District Court of Darjeelingintellectual_propertycivil

IPRS v. Hotel Appolo: Licensing and Copyright Issues

The dispute in IPRS v. Hotel Appolo addresses critical issues regarding copyright licensing in the context of hotel services. Legal experts analyze the implications of the case for hotel operators and copyright societies.

Sep 8, 2026Read more →
PreviousPage 29 of 48Next